May 11, 2022
Medipure Pharmaceuticals Inc. a Vancouver, British Columbia-based biopharmaceutical company conducting research in prescription pharmaceuticals, and its parent company Medipure Holdings Inc., each filed an NOI on May 11. At the time of the filing, the companies' secured and unsecured creditor, SHP Capital, LLC, had an outstanding bankruptcy application against the companies, which was to be heard on May 13. Deloitte is the proposal trustee. Counsel is Boughton Law for the companies and Bennett Jones for SHP Capital.
By Dina Milivojevic